Ibogaine

Ibogaine and its studies have had a renewed interest in the past decades due to the interest in effects that ibogaine has on cessation of drug addiction. It has been proven in pre-clinical trials to reduce self-administration of cocaine, morphine, and amphetamines. It is said that ibogaine breaks patterns of addiction, whether the addiction in question is physical or emotional. Ibogaine is also still believed to provide insight and guidance into a person's life.

Recent studies have shown that ibogaine and its primary metabolite interact with numerous neuroreceptors and neurotransporters within the cellular networks that modulate the activity of dopaminergic-dependent and independent circuits. The multi-site actions of ibogaine suggest that simultaneous modulation of more than one neural mechanism may therefore be an effective pharmacological treatment approach.

Ibogaine's actions are reported to reduce dopamine concentrations in the body. This is proven by the presence of dopamine metabolites dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in increased amounts after ibogaine administration. This action of ibogaine is what is thought to reverse the affects of certain abusive and highly addictive drugsand highly addictive drugs, namely/specifically: cocaine, morphine, amphetamines and nicotine. All of these drugs act upon dopaminergic systems and they will stimulate dopamine production in the body. Ibogaine is thought to reverse this process by antagonizing dopaminergic systems. Ibogaine is also thought to reduce addiction because it can inhibit naloxone which will precipitate the blockade of NMDA channels. Ibogaine can readily affect serotonergic transmission in the brain, as this has been observed in clinical studies. But once again the mechanisms of action on the many serotonergic receptors are complex and not completely understood. We can see that the actions in the body are not completely understood.

Most interestingly, ibogaine is proven to inhibit self-administration of cocaine in rats. In fact, one dose of ibogaine would decrease cocaine consumption in 5 days by 60-80%. Ibogaine was also found to lower the self-administration of morphine and alcohol.

Psychologically, ibogaine is capable of producing visions and hallucinations at high doses. It has been established that ibogaine affects the central nervous system in a variety of ways. Many studies have been conducted regarding the behavioral effects of ibogaine on drug-dependent patients. Ibogaine was found to produce no significant neurobehavioral impairments. Acute effects included mild tremors and a dramatic resurgence of repressed memories. These visions sometimes lasted up to 8 hours and eventually subsided into a 24-hour state of relaxation. Some patients also experience mild insomnia after the treatment, but this did not affect their sensorium (sensations).



The Benefits of Ibogaine

Studies undertaken by leading research and academic facilities have shown that ibogaine is invaluable in treating physical dependency and the associated withdrawal symptoms of Heroin, Methadone, and Prescription Opiates. It alleviates 90% of opiate withdrawal symptoms and can address cravings for two to six months. At the same time it changes habitual thought patterns and helps to restore the proper functioning of the brain's neurochemistry that, if left untreated, can make it so difficult to stay free of addiction.

Ibogaine is also extremely beneficial in the treatment of Alcohol, Cocaine, Methamphetamine, and/or Nicotine addiction because it resets the dopamine uptake pathways in the pleasure and craving centers of the mind that are thrown out of balance by the abuse of these substances. There is no other known substance that addresses these areas with such magnitude and accuracy.

Ibogaine is an incredibly useful tool in breaking through old habits and patterns that keep us separate from our true nature. By resolving past traumatic events, one is able to live in the present moment free from chemical dependency and lingering desire. It has proven useful in treating a wide variety of psycho-spiritual maladies that often underlie the addiction process including: Autism, Depression, Childhood Trauma, PTSD, Compulsive Fear, Bi-Polar Disorder, and OCD.

Ibogaine is an Addiction Interrupter

Ibogaine is the ONLY product in combination with Oxidative/Ozone therapy that can remove opiate and other addictions WITHOUT causing harsh withdrawal symptoms.

Ibogaine breaks the pattern of addiction, Ozone/Oxygen DETOXIFIES the body by rapidly cleaning the blood system and liver of toxins. Ibogaine’s metabolite Nor-Ibogaine is an opiate agonist and is NON-ADDICTIVE.

When a person is addicted to opiates of any kind, their Central Nervous System is adjusted to having the opioid receptors filled. The withdrawal syndrome starts when the addict suddenly stops using drugs. Nor-Ibogaine fills in the opioid receptors, replacing the narcotics, thereby tricking the brain into believing it is receiving opiates. There is NO withdrawal from Nor-Ibogaine!!! Nor-Ibogaine is produced in the body and believed to be stored in the liver after taking Ibogaine. Nor-Ibogaine stays in the body for at least a month to 60 days and continues to act in and refill the opioid receptors related to drug usage. The Oxygen/Ozone therapy continuously breaks down chemicals and toxins built up and stored in the body by years of substance abuse/toxicity. The metabolized version of Ibogaine (Nor-Ibogaine) causes the addict to have a reduction in craving for a period of time from several weeks to months. Nor-Ibogaine also has anti-depressant properties, which is important for the recovering patient.(Ozone enhances the anti-depressant qualities of Nor-Ibogaine)

Combined with Oxygen/Ozone therapy, which significantly fortifies the immune system the patient feels noticeably better very quickly.
Ibogaine coupled with Oxidative/Ozone is a biological and psycho/therapeutic catalyst for change. When Ibogaine is accompanied with Oxidative/Ozone therapy, diet, light daily exercise, counseling and the promise of long-term abstinence is greatly increased.